ED
CACI icon

Exane Derivatives’s CACI CACI Stock Holding History

Exane Derivatives’s Portfolio CACI Stock Details CACI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-152
Closed -$37.5K – 1051
2021
Q1 		$37.5K Buy
+152
New +$36.4K 0.01% 538
2019
Q2 		– Sell
-1
Closed -$182 – 668
2019
Q1 		$182 Sell
1
-14,617
-100% -$2.49M ﹤0.01% 570
2018
Q4 		$2.1M Buy
+14,618
New +$2.49M 0.38% 76

Other funds holding CACI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

Exane Derivatives's CACI Position: Q2 2021 in Review

Exane Derivatives sold out of CACI (CACI) in Q2 2021, closing a stake of 152 shares — an estimated $37.5K sold.

Exane Derivatives first reported a position in CACI in Q4 2018 and held it in 3 quarters. The position peaked at $2.1M in Q4 2018. 392 funds tracked by Wall St. Rank hold CACI as of Q2 2021.

  • Exane Derivatives reported no remaining CACI position as of Q2 2021 after selling out during the quarter.
  • Exane Derivatives sold 152 CACI shares in Q2 2021, an estimated $37.5K.
  • Exane Derivatives first reported a position in CACI in Q4 2018 and held it in 3 quarters.
  • Exane Derivatives's CACI position peaked at $2.1M in Q4 2018.
  • 392 funds tracked by Wall St. Rank held CACI as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.